Hyperaldosteronism
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
This page contains general information about Hyperaldosteronism. For more information on specific types, please visit the pages on Primary hyperaldosteronism, and Secondary hyperaldosteronism.
Synonyms and keywords: Aldosteronism
Overview
Classification
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:
Cause | Laboratory | |||||
---|---|---|---|---|---|---|
Renin activity | Aldosterone levels | urinary free cortisone | ||||
Primary hyperaldosteronism | Renin-producing tumors | ↑ | ↑ | ↓ | ||
Secondary hyperaldosteronism | Apparent mineralocorticoid excess | ↓ | ↓ | ↓↓ | ||
Licorice ingestion | ↓ | ↓ | Moderate ↑ | |||
Ectopic ACTH production | ↓ | ↑ | Markedly ↑↑ | |||
Primary hyperaldosteronism | ↓ | ↑ | ↓ | |||
Familial hyperaldosteronism | ↓ | ↑ | ↓ | |||
Cushing syndrome | ↓ | ↑ | Markedly ↑↑ | |||
Renal artery stenosis | ↑ | ↑ | ↓ | |||
Liddle's syndrome | ↓ | ↓ | ↓ | |||
Diuretic use | Nl | ↓ | ||||
17 alpha hydroxylase deficiency | ↓ | ↓ | ↓ | |||
11 beta hydroxylase deficiency | ↓ | ↓ | ↓ | |||
Coarctation of aorta | ↓ |
Pseudohyperaldosteronism causes:
Pseudohyperaldosteronism causes | Disease | Cause | Labratory | ||||
---|---|---|---|---|---|---|---|
Elevated mineralocorticoid | Renin | Aldosterone | Treatment | ||||
Endogenous causes | Deficiency of 17a-hydroxylase | Deoxycorticosterone (DOC) | ↓ | ↓ | |||
11b-hydroxylase | |||||||
Apparent mineralocorticoid excess syndrome (AME) | Genetic or acquired defect of 11-HSD | ↓ | ↓ | dexamethasone and/or MR-blockers | |||
Liddle’s syndrome | Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules | ↓ | ↓ | amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone | |||
Cushing’s syndrome | The main pathogenetic mechanism is linked to the excess
of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids. |
||||||
Insensitivity to glucocorticoids (Chrousos syndrome) | mutations in glucocorticoid receptor (GR) gene | Deoxycorticosterone (DOC) | ↓ | ↓ | dexamethasone | ||
Aldosterone-secreting adrenocortical carcinoma | |||||||
Geller’s syndrome | mutation of MR that alters its specificity and allows progesterone to bind MR | severe hypertension particularly during pregnancy | ↓ | ↓ | |||
Gordon’s syndrome or pseudohypoaldosteronism type 2 | due to different mutations correlated to different phenotypes. Mutations of at least four genes have been identified, including WNK1 and WNK4 | hypertension, characterized by hyperkalemia, normal renal function | ↓ | ↓ | thiazide diuretics and/or dietary sodium restriction | ||
Exogenous causes | Corticosteroids with mineralocorticoid activity | ||||||
Hypersodic diets | |||||||
Water intossications | |||||||
Licorice | |||||||
grapefruit | |||||||
Contraceptives | |||||||
Some progestins | |||||||
Particular causes of hypertension | Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly) | ||||||
FANS | |||||||
B-Adrenergic agonists | |||||||
Aging | |||||||
Low-renin essential hypertension | |||||||
Autonomic dysfunction | |||||||
Partial/total nephrectomy or removal of renal tissue |
Differentiating Diagnosis
Hyperaldosteronism should be differentiated from other diseases causing hypertension and hypokalemia for example:
- Renal artery stenosis
- Cushing's syndrome
- Congenital adrenal hyperplasia (CAH)
- Liddle's syndrome
- Diuretic use
- Licorice ingestion
- Renin-secreting tumors
Hypertension and Hypokalemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma renin activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High (Plasma Renin/Aldosterone ratio <10 | Suppressed (Plasma Renin/Aldosterone ratio >20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Renin-secreting tumors *Diuretic use *Renovascular hypertension *Coarctation of aorta *Malignant phase hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K+ depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion • Deoxycortisone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add Mineralocrticoid antagonist for 8 weeks | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency) • Licorice ingestion •Glucocorticoid resistance | Liddle's syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||